Navigating Treatment Options for Alzheimer’s and Dementia: What You Need to Know


Navigating Treatment Options for Alzheimer’s and Dementia: What You Need to Know


As research into Alzheimer’s disease and dementia continues to progress, so too do the available treatment options. While there is still no cure, new FDA-approved drugs offer hope by slowing cognitive decline in people diagnosed in the early stages. Navigating these treatments can feel overwhelming, but understanding your options is the first step toward informed and empowered care.

Alzheimer’s disease is a progressive brain disorder that impacts memory, thinking, and behavior. It is the most common cause of dementia. As the disease advances, brain cells are damaged and connections are lost, leading to worsening symptoms. While some medications help manage these symptoms temporarily, others aim to slow the actual progression of the disease.


Recently, the FDA approved two breakthrough drugs—Donanemab (Kisunla™) and Lecanemab (Leqembi®)—for individuals in the early stages of Alzheimer’s. Both are intravenous (IV) infusion therapies that work by targeting beta-amyloid plaques in the brain, which are linked to Alzheimer’s progression. Clinical trials show these drugs can slow memory and functional decline when administered to patients with mild cognitive impairment or mild dementia and confirmed elevated beta-amyloid levels. Side effects such as headaches and imaging abnormalities may occur, so it’s essential these treatments are closely monitored by a doctor.


Early diagnosis is critical. Not only does it increase the chance of benefiting from these new treatments, but it also allows individuals and families to plan for the future while the person still has the ability to participate in decisions. Your doctor will assess your symptoms, stage of the disease, and medical history to determine if one of these treatments might be right for you.


Lionell Martin, Alzheimer’s Association Illinois Chapter, Phone: 773.593.4211

Email: lrmartin@alz.org

About the Alzheimer’s Association Illinois Chapter

The Alzheimer’s Association offers a 24/7 Helpline (800-272-3900) that is available 365 days a year. Specialists and master’s-level clinicians provide confidential support and information to individuals living with dementia, caregivers, families, and the public.


Latest Stories

Latest Podcast

Reverse Mortgages